Hotel, Resort & Restaurants · Founded 1986 · www.royalorchidhotels.com · BSE 532699 · NSE ROYALORCH · ISIN INE283H01019
No Notes Added Yet
Business
Royal Orchid Hotels Ltd. is an Indian hospitality company engaged in the ownership, management, and franchising of hotels and resorts. The company operates a portfolio of properties primarily across India, catering to business and leisure travelers. Its core business model involves generating revenue from room tariffs, food and beverage sales, banqueting, and other ancillary services. It also earns fees from managing and franchising properties under its various brands, which include Royal Orchid, Regenta by Royal Orchid, and Royal Orchid Central, primarily targeting the upscale and mid-market segments.
Revenue Mix
The company's revenue primarily derives from its owned, leased, and managed hotel properties. The key revenue streams include:
Room Revenue: From guest stays in its hotels and resorts.
Food & Beverage Revenue: From restaurants, bars, in-room dining, and banquet services.
Other Operating Revenues: Includes income from laundry, spa services, business center facilities, and management/franchise fees from properties operated under its brands but not owned by the company.
Specific percentage contributions for each segment are not consistently broken down in public statements, but room and F&B revenues typically constitute the largest portions for full-service hotels.
Industry
The Indian hotel industry is diverse and highly competitive, characterized by both organized national and international players and a large unorganized sector. Royal Orchid Hotels operates predominantly in the mid-market to upscale segment. While it does not possess the scale or luxury positioning of larger players like Taj, ITC Hotels, or Oberoi, it has established a significant pan-India presence with a growing portfolio of properties in key business and leisure destinations. Its strategy often involves expanding through asset-light models (management contracts and franchises) to compete effectively against both established domestic chains and international brands entering the market.
MOAT
Royal Orchid Hotels' competitive advantages are relatively moderate within the fragmented hospitality sector:
Brand Recognition: Its brands (Royal Orchid, Regenta) have established recognition within the mid-to-upscale segments in various Indian cities, fostering a degree of customer loyalty.
Asset-Light Expansion: A growing proportion of managed and franchised properties allows for expansion without significant capital expenditure, providing flexibility and better returns on capital compared to solely owning assets.
Strategic Locations: Many of its properties are located in key business hubs and tourist destinations, benefiting from consistent demand.
Operational Experience: Over two decades of experience in the Indian hospitality market provides operational efficiencies and understanding of local market dynamics.
Growth Drivers
Rising Disposable Incomes & Domestic Tourism: India's growing middle class and increasing propensity for travel are key drivers for leisure and business tourism.
MICE Segment Growth: The Meetings, Incentives, Conferences, and Exhibitions (MICE) segment continues to grow, boosting demand for hotel accommodations and banqueting facilities.
Infrastructure Development: Improved air and road connectivity, along with new airports, enhances accessibility to various destinations, benefiting hotels.
Asset-Light Expansion Strategy: The focus on management contracts and franchises enables quicker expansion of its brand footprint with lower capital outlay, driving revenue and fee income.
Business Travel Revival: Post-pandemic recovery in corporate travel and economic activity fuels demand for business hotels.
Risks
Economic Downturn: A slowdown in the Indian economy can significantly impact discretionary travel and corporate spending, leading to lower occupancy and average room rates (ARRs).
Intense Competition: The hospitality sector is highly competitive with numerous domestic and international players, leading to pricing pressures and challenges in maintaining market share.
High Capital Expenditure & Debt: While pursuing an asset-light model, owned properties require significant capital investment and can lead to higher debt levels, impacting profitability during downturns.
Seasonality & Cyclicality: Demand for hotels is often seasonal and cyclical, influenced by holidays, weather, and economic cycles.
Input Cost Inflation: Rising costs of food, energy, labor, and other operational expenses can squeeze profit margins.
Geopolitical and Health Events: External shocks like pandemics, natural disasters, or geopolitical tensions can severely disrupt the travel and tourism industry.
Management & Ownership
Royal Orchid Hotels Ltd. is promoted by the Chabria family. Mr. Chander K. Baljee is the Chairman and Managing Director, with long-standing experience in the hospitality sector, having founded the company. The management team has a blend of experience in hotel operations and finance. The promoter group holds a significant stake in the company, aligning their interests with long-term growth. Institutional and public shareholders hold the remaining shares, contributing to a diversified ownership structure.
Outlook
Royal Orchid Hotels is positioned to benefit from the ongoing tailwinds in the Indian hospitality sector, driven by robust domestic demand, increasing travel, and business activity. The company's strategy of expanding through an asset-light model, coupled with its established brand presence in the mid-to-upscale segment, provides a pathway for growth and improved operational efficiencies. However, the outlook is tempered by the inherently competitive nature of the industry, the potential for economic volatility impacting discretionary spending, and persistent inflationary pressures on operating costs. Its ability to navigate these challenges while effectively executing its expansion strategy will be crucial for sustainable performance and market share gains.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
| #(Fig in Cr.) | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 76 | 73 | 70 | 89 | 87 | 79 | 79 | 113 | 113 | 107 |
| Other Income | 6 | 5 | 8 | 6 | 6 | 4 | 8 | 5 | 6 | 7 |
| Total Income | 82 | 78 | 78 | 95 | 92 | 83 | 87 | 118 | 119 | 115 |
| Total Expenditure | 58 | 56 | 59 | 64 | 67 | 59 | 66 | 83 | 88 | 82 |
| Operating Profit | 24 | 21 | 19 | 31 | 26 | 24 | 21 | 35 | 31 | 33 |
| Interest | 4 | 4 | 4 | 4 | 4 | 4 | 9 | 13 | 13 | 13 |
| Depreciation | 5 | 5 | 5 | 5 | 5 | 5 | 8 | 11 | 11 | 12 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 |
| Profit Before Tax | 14 | 12 | 10 | 22 | 16 | 15 | 4 | 10 | 9 | 8 |
| Provision for Tax | -1 | 3 | 3 | 5 | 5 | 4 | 1 | 3 | 3 | 2 |
| Profit After Tax | 15 | 9 | 7 | 16 | 11 | 11 | 4 | 8 | 6 | 6 |
| Adjustments | 1 | 0 | 1 | 1 | 2 | 0 | 1 | 1 | 1 | 1 |
| Profit After Adjustments | 17 | 9 | 8 | 18 | 13 | 11 | 4 | 9 | 8 | 6 |
| Adjusted Earnings Per Share | 6.1 | 3.2 | 2.7 | 6.5 | 4.8 | 4 | 1.6 | 3.3 | 2.9 | 2.3 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 159 | 175 | 189 | 204 | 205 | 81 | 139 | 264 | 294 | 319 | 384 | 412 |
| Other Income | 4 | 13 | 10 | 15 | 15 | 8 | 17 | 16 | 19 | 24 | 22 | 26 |
| Total Income | 163 | 188 | 200 | 219 | 220 | 89 | 156 | 280 | 313 | 343 | 406 | 439 |
| Total Expenditure | 138 | 156 | 160 | 170 | 174 | 92 | 115 | 182 | 218 | 246 | 296 | 319 |
| Operating Profit | 25 | 32 | 39 | 49 | 46 | -3 | 41 | 98 | 95 | 97 | 111 | 120 |
| Interest | 15 | 16 | 16 | 14 | 16 | 16 | 17 | 16 | 18 | 17 | 39 | 48 |
| Depreciation | 14 | 16 | 16 | 14 | 19 | 19 | 19 | 18 | 20 | 21 | 36 | 42 |
| Exceptional Income / Expenses | 1 | 0 | 1 | 0 | 0 | -7 | 25 | 0 | 0 | 0 | 2 | 2 |
| Profit Before Tax | -3 | 0 | 9 | 21 | 11 | -46 | 30 | 64 | 57 | 59 | 38 | 31 |
| Provision for Tax | 1 | 5 | 7 | 8 | 6 | -6 | 3 | 17 | 10 | 16 | 10 | 9 |
| Profit After Tax | -4 | -5 | 2 | 13 | 5 | -40 | 27 | 47 | 47 | 43 | 29 | 24 |
| Adjustments | 2 | 1 | 1 | -1 | -0 | 8 | 3 | 0 | 1 | 4 | 4 | 4 |
| Profit After Adjustments | -1 | -3 | 3 | 12 | 5 | -32 | 29 | 47 | 48 | 47 | 32 | 27 |
| Adjusted Earnings Per Share | -0.5 | -1.3 | 1.2 | 4.4 | 1.8 | -11.8 | 10.7 | 17.1 | 17.7 | 17.2 | 11.7 | 10.1 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 20% | 13% | 37% | 9% |
| Operating Profit CAGR | 14% | 4% | 0% | 16% |
| PAT CAGR | -33% | -15% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -43% | -1% | 25% | 16% |
| ROE Average | 12% | 19% | 22% | 8% |
| ROCE Average | 22% | 26% | 27% | 15% |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 160 | 166 | 169 | 177 | 173 | 140 | 125 | 173 | 191 | 231 | 258 |
| Minority's Interest | 37 | 48 | 45 | 44 | 42 | 33 | 22 | 24 | 17 | 16 | 17 |
| Borrowings | 59 | 101 | 96 | 89 | 85 | 94 | 72 | 65 | 47 | 79 | 82 |
| Other Non-Current Liabilities | 5 | 4 | 3 | 2 | 49 | 40 | 58 | 74 | 113 | 101 | 519 |
| Total Current Liabilities | 81 | 82 | 84 | 97 | 95 | 101 | 77 | 80 | 89 | 99 | 146 |
| Total Liabilities | 342 | 401 | 397 | 410 | 444 | 408 | 354 | 417 | 457 | 526 | 1023 |
| Fixed Assets | 238 | 286 | 272 | 264 | 307 | 243 | 193 | 206 | 255 | 253 | 730 |
| Other Non-Current Assets | 67 | 53 | 55 | 56 | 61 | 38 | 65 | 78 | 85 | 149 | 114 |
| Total Current Assets | 37 | 55 | 62 | 82 | 75 | 64 | 82 | 116 | 101 | 122 | 155 |
| Total Assets | 342 | 401 | 397 | 410 | 444 | 408 | 354 | 417 | 457 | 526 | 1023 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 12 | 9 | 15 | 21 | 35 | 20 | 13 | 19 | 40 | 24 | 27 |
| Cash Flow from Operating Activities | 23 | 27 | 25 | 41 | 29 | 5 | 22 | 56 | 59 | 25 | 82 |
| Cash Flow from Investing Activities | -7 | -9 | -1 | -5 | -16 | -11 | -3 | -9 | -37 | -22 | -39 |
| Cash Flow from Financing Activities | -16 | -11 | -18 | -23 | -28 | -1 | -13 | -25 | -39 | -0 | -56 |
| Net Cash Inflow / Outflow | -0 | 7 | 6 | 13 | -15 | -6 | 6 | 21 | -16 | 3 | -13 |
| Closing Cash & Cash Equivalent | 12 | 15 | 21 | 35 | 20 | 13 | 19 | 40 | 24 | 27 | 14 |
| # | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | -0.48 | -1.27 | 1.23 | 4.36 | 1.79 | -11.84 | 10.71 | 17.15 | 17.68 | 17.23 | 11.74 |
| CEPS(Rs) | 3.77 | 4.25 | 6.68 | 10.01 | 8.77 | -7.56 | 16.86 | 23.81 | 24.51 | 23.28 | 23.4 |
| DPS(Rs) | 0 | 1 | 1.5 | 2 | 0 | 0 | 0 | 2 | 2.5 | 2.5 | 2.5 |
| Book NAV/Share(Rs) | 58.68 | 58.23 | 59.06 | 61.98 | 63.01 | 51.08 | 45.65 | 63.07 | 69.55 | 84.16 | 94.13 |
| Core EBITDA Margin(%) | 12.94 | 11.05 | 15.37 | 16.8 | 14.96 | -13.6 | 17.13 | 31.07 | 25.91 | 22.87 | 23 |
| EBIT Margin(%) | 7.76 | 9.12 | 13.17 | 17.25 | 13.03 | -36.59 | 33.74 | 30.22 | 25.65 | 23.81 | 20.1 |
| Pre Tax Margin(%) | -1.77 | 0.06 | 4.87 | 10.44 | 5.22 | -56.92 | 21.56 | 24.13 | 19.43 | 18.62 | 9.99 |
| PAT Margin (%) | -2.3 | -2.61 | 1.27 | 6.43 | 2.48 | -49.49 | 19.34 | 17.81 | 16.13 | 13.5 | 7.43 |
| Cash Profit Margin (%) | 6.47 | 6.61 | 9.62 | 13.46 | 11.74 | -25.63 | 33.37 | 24.78 | 22.9 | 19.99 | 16.7 |
| ROA(%) | -1.06 | -1.23 | 0.6 | 3.25 | 1.19 | -9.39 | 7.02 | 12.18 | 10.84 | 8.78 | 3.69 |
| ROE(%) | -2.26 | -2.86 | 1.51 | 7.92 | 2.96 | -25.58 | 20.19 | 31.49 | 26.05 | 20.46 | 11.68 |
| ROCE(%) | 4.97 | 6.22 | 9.25 | 12.99 | 9.84 | -11.37 | 20.53 | 35.11 | 29.76 | 25.84 | 22.48 |
| Receivable days | 35.34 | 35.54 | 40.56 | 37.48 | 37.24 | 74.23 | 40.11 | 36.61 | 40.38 | 37.04 | 33.14 |
| Inventory Days | 4.83 | 4.52 | 4.3 | 4.17 | 4.09 | 9.27 | 5.02 | 2.89 | 3 | 3.03 | 2.74 |
| Payable days | 493.35 | 530.93 | 579.74 | 556.79 | 506.64 | 1011.95 | 822.18 | 514.29 | 437 | 383.1 | 386.01 |
| PER(x) | 0 | 0 | 130.9 | 27.1 | 22.89 | 0 | 11.42 | 15.79 | 20.49 | 22.76 | 23.09 |
| Price/Book(x) | 1.2 | 1.54 | 2.72 | 1.91 | 0.65 | 1.23 | 2.68 | 4.29 | 5.21 | 4.66 | 2.88 |
| Dividend Yield(%) | 0 | 1.12 | 0.93 | 1.69 | 0 | 0 | 0 | 0.74 | 0.69 | 0.64 | 0.92 |
| EV/Net Sales(x) | 1.64 | 1.9 | 2.74 | 1.88 | 0.83 | 2.94 | 2.66 | 2.83 | 3.44 | 3.5 | 2.09 |
| EV/Core EBITDA(x) | 10.47 | 10.37 | 13.19 | 7.76 | 3.71 | -79.09 | 8.96 | 7.61 | 10.61 | 11.56 | 7.24 |
| Net Sales Growth(%) | 7.29 | 10.31 | 8.34 | 7.59 | 0.59 | -60.57 | 71.33 | 90.26 | 11.41 | 8.81 | 20.25 |
| EBIT Growth(%) | 16.5 | 29.69 | 56.43 | 40.86 | -23.99 | -210.69 | 258.03 | 70.4 | -5.47 | 1 | 1.51 |
| PAT Growth(%) | 46.33 | -25.06 | 152.95 | 443.51 | -61.27 | -888.04 | 166.94 | 75.24 | 0.91 | -8.95 | -33.78 |
| EPS Growth(%) | 66.36 | -166.09 | 196.62 | 254.85 | -58.9 | -761.13 | 190.42 | 60.14 | 3.12 | -2.57 | -31.88 |
| Debt/Equity(x) | 0.52 | 0.7 | 0.66 | 0.6 | 0.56 | 0.78 | 0.64 | 0.44 | 0.35 | 0.43 | 0.38 |
| Current Ratio(x) | 0.45 | 0.66 | 0.75 | 0.85 | 0.8 | 0.64 | 1.06 | 1.45 | 1.14 | 1.23 | 1.06 |
| Quick Ratio(x) | 0.43 | 0.66 | 0.72 | 0.83 | 0.79 | 0.62 | 1.04 | 1.43 | 1.11 | 1.2 | 1.04 |
| Interest Cover(x) | 0.81 | 1.01 | 1.59 | 2.53 | 1.67 | -1.8 | 2.77 | 4.96 | 4.12 | 4.59 | 1.99 |
| Total Debt/Mcap(x) | 0.43 | 0.46 | 0.24 | 0.31 | 0.87 | 0.63 | 0.24 | 0.1 | 0.07 | 0.09 | 0.13 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 63.6 | 63.65 | 63.65 | 63.65 | 63.7 | 63.89 | 63.89 | 64.06 | 64.06 | 64.06 |
| FII | 6.07 | 6.52 | 6.68 | 6.67 | 7.3 | 7.72 | 8.3 | 8.32 | 8.54 | 8.57 |
| DII | 0.66 | 0.67 | 0.67 | 0.71 | 0.73 | 0.8 | 0.81 | 0.84 | 0.87 | 0.91 |
| Public | 29.68 | 29.15 | 29 | 28.97 | 28.27 | 27.59 | 27 | 26.78 | 26.53 | 26.46 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 1.74 | 1.75 | 1.75 | 1.75 | 1.75 | 1.75 | 1.75 | 1.76 | 1.76 | 1.76 |
| FII | 0.17 | 0.18 | 0.18 | 0.18 | 0.2 | 0.21 | 0.23 | 0.23 | 0.23 | 0.23 |
| DII | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
| Public | 0.81 | 0.8 | 0.8 | 0.79 | 0.78 | 0.76 | 0.74 | 0.73 | 0.73 | 0.73 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2.74 | 2.74 | 2.74 | 2.74 | 2.74 | 2.74 | 2.74 | 2.74 | 2.74 | 2.74 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +20% | +13% | +37% | +9% |
| Operating Profit CAGR | +14% | +4% | — | +16% |
| PAT CAGR | -33% | -15% | — | — |
| Share Price CAGR | -43% | -1% | +25% | +16% |
| ROE Average | +12% | +19% | +22% | +8% |
| ROCE Average | +22% | +26% | +27% | +15% |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 63.6 | 63.65 | 63.65 | 63.65 | 63.7 | 63.89 | 63.89 | 64.06 | 64.06 | 64.06 |
| FII | 6.07 | 6.52 | 6.68 | 6.67 | 7.3 | 7.72 | 8.3 | 8.32 | 8.54 | 8.57 |
| DII | 0.66 | 0.67 | 0.67 | 0.71 | 0.73 | 0.8 | 0.81 | 0.84 | 0.87 | 0.91 |
| Public | 29.68 | 29.15 | 29 | 28.97 | 28.27 | 27.59 | 27 | 26.78 | 26.53 | 26.46 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 1.74 | 1.75 | 1.75 | 1.75 | 1.75 | 1.75 | 1.75 | 1.76 | 1.76 | 1.76 |
| FII | 0.17 | 0.18 | 0.18 | 0.18 | 0.2 | 0.21 | 0.23 | 0.23 | 0.23 | 0.23 |
| DII | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
| Public | 0.81 | 0.8 | 0.8 | 0.79 | 0.78 | 0.76 | 0.74 | 0.73 | 0.73 | 0.73 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2.74 | 2.74 | 2.74 | 2.74 | 2.74 | 2.74 | 2.74 | 2.74 | 2.74 | 2.74 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
Your relationship manager will connect with you shortly.